ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

SABSW SAB Biotherapeutics Inc

0.0367
0.00428 (13.18%)
Pre Market
Last Updated: 07:50:14
Delayed by 15 minutes

SAB Biotherapeutics Financial Summary

The current SABSW market cap is 1.92M. The company's latest EPS is USD -0.8065 and P/E is -4.28.

Quarter End Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
USD ($)USD ($)USD ($)USD ($)
Total Revenue 2.16M581k86k1.27M305k
Operating Income -7.86M-7.4M-6.48M-5.32M-18.87M
Net Income -7.88M-7.35M-6.88M-5.1M-22.86M
Year End December 30 2023 2020202120222023
USD ($)USD ($)USD ($)USD ($)
Total Revenue 060.88M23.9M2.24M
Operating Income -9k-13.39M-28.92M-38.08M
Net Income -9k-17.15M-18.74M-42.19M
Quarter End Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
USD ($)USD ($)USD ($)USD ($)
Total Assets 50.91M42.67M35.44M28.34M83.94M
Total Liabilities 19.85M18.27M15.73M13.08M26.64M
Total Equity 31.06M24.4M19.72M15.26M57.3M
Year End December 30 2023 2020202120222023
USD ($)USD ($)USD ($)USD ($)
Total Assets 322k79.37M50.91M83.94M
Total Liabilities 306k40.82M19.85M26.64M
Total Equity 16k38.55M31.06M57.3M
Quarter End Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
USD ($)USD ($)USD ($)USD ($)
Operating -23.46M-1.61M-6.51M-11.67M-25.12M
Investing -2.09M-21k-44k-85k-153k
Financing 1.05M-360k-724k-864k66.77M
Year End December 30 2023 2020202120222023
USD ($)USD ($)USD ($)USD ($)
Operating -10k3.76M-23.46M-25.12M
Investing N/A -10.94M-2.09M-153k
Financing 95k34.12M1.05M66.77M
Market Cap 1.92M
Price to Earnings Ratio -4.28
Price to Sales Ratio 80.61
Price to Cash Ratio 3.19
Price to Book Ratio 3.15
Dividend Yield -

Share Statistics

Shares Outstanding 52.32M
Average Volume (1 week) 0
Average Volume (1 Month) 0
52 Week Change -
52 Week High -
52 Week Low -
Spread (Intraday) 0 (8.25%)

Company Info

Company Name SAB Biotherapeutics Inc
Address 251 little falls drive
wilmington, delaware 19808
Website https://www.sab.bio
Industry blank checks (6770)